Literature DB >> 10147920

Percutaneous transvenous balloon mitral commissurotomy: When? For whom? An alternative to surgery in symptomatic mitral stenosis.

T Feldman1, J D Carroll.   

Abstract

Percutaneous transvenous mitral commissurotomy (PTMC) is the therapy of choice for patients with mitral stenosis who are candidates for commissurotomy. PTMC also offers palliative therapy for patients who are not good surgical candidates. Patients with thin, pliable valve leaflets and little subvalvular disease are the best suited. Significant thrombus in the left atrium is a strong relative contraindication. PTMC with the Inoue balloon is technically easier to perform than is conventional balloon valvotomy and is better tolerated by most patients. During this procedure, the Inoue balloon is positioned against the mitral valve; it is repeatedly inflated at increasing balloon diameters until the transmitral valve gradient is sufficiently relieved. PTMC affords marked symptomatic improvement in most patients who undergo the procedure.

Entities:  

Mesh:

Year:  1991        PMID: 10147920

Source DB:  PubMed          Journal:  J Crit Illn        ISSN: 1040-0257


  2 in total

1.  Immediate, intermediate and long term clinical outcomes of percutaneous transvenous mitral commissurotomy.

Authors:  Satya Narayana Murthy Jayanthi Sriram; Balasubramaniyan Jayanthi Venkata; Thanikachalam Sadagopan; Muralidharan Thodi Ramamurthy
Journal:  Int J Cardiol Heart Vasc       Date:  2015-01-15

Review 2.  The COVID-19 Pandemic Surge and Impact on Rheumatic Valvular Heart Disease Patient Care.

Authors:  Prashanth Kulkarni; Manjappa Mahadevappa
Journal:  J Saudi Heart Assoc       Date:  2021-11-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.